SELLAS Life Sciences (SLS) Other Accumulated Expenses (2011 - 2018)

SELLAS Life Sciences (SLS) has 5 years of Other Accumulated Expenses data on file, last reported at $1.3 million in Q1 2018.

• Quarterly Other Accumulated Expenses rose 36.84% year-over-year to $1.3 million in Q1 2018, while the trailing twelve-month figure through Mar 2018 was $1.3 million (up 36.84% YoY) and the FY2017 annual result came in at $1.3 million, up 472.69% from the prior year.
• Other Accumulated Expenses held at $1.3 million in Q1 2018 per SLS's latest filing, from $1.3 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $25.0 million in Q4 2015 and bottomed at $227000.0 in Q4 2016.
• The 4-year median for Other Accumulated Expenses is $1.3 million (2017), against an average of $4.6 million.
• The widest annual swing landed in 2016, when Other Accumulated Expenses plunged 99.09%; it then jumped 472.69% in 2017.
• Tracing SLS's Other Accumulated Expenses over 4 years: stood at $25.0 million in 2015, then sank by 99.09% to $227000.0 in 2016, then jumped by 472.69% to $1.3 million in 2017, then changed by 0.0% to $1.3 million in 2018.
• Per Business Quant, the three latest SLS Other Accumulated Expenses figures stand at $1.3 million (Q1 2018), $1.3 million (Q4 2017), and $1.3 million (Q3 2017).

Peer Comparison